Aminocarboxymuconate Semialdehyde Decarboxylase (ACMSD) (Middle Region) Peptide
-
- Target See all ACMSD products
- ACMSD (Aminocarboxymuconate Semialdehyde Decarboxylase (ACMSD))
- Protein Region
- Middle Region
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-ACMSD antibody (Catalog #: ARP45728_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
-
- Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handling Advice
- Avoid repeated freeze-thaw cycles.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- ACMSD (Aminocarboxymuconate Semialdehyde Decarboxylase (ACMSD))
- Synonyms
- zgc:162888 Peptide, ACMSD Peptide, aminocarboxymuconate semialdehyde decarboxylase Peptide, aminocarboxymuconate semialdehyde decarboxylase S homeolog Peptide, amino carboxymuconate semialdehyde decarboxylase Peptide, ACMSD Peptide, acmsd Peptide, acmsd.S Peptide, Acmsd Peptide
- Background
-
The neuronal excitotoxin quinolinate is an intermediate in the de novo synthesis pathway of NAD from tryptophan, and has been implicated in the pathogenesis of several neurodegenerative disorders. Quinolinate is derived from alpha-amino-beta-carboxy-mucon
Alias Symbols: -
Protein Interaction Partner: MAGEA11,MAGEA11
Protein Size: 336 - Molecular Weight
- 38 kDa
- Gene ID
- 130013
- NCBI Accession
- NM_138326, NP_612199
- UniProt
- Q8TDX5
-